Expand MNKD Menu
MNKD MENU

MNKD Stock Summary and Trading Ideas (Mannkind | NASDAQ:MNKD)

Charts for Today's Stock Price and Implied Volatility in Mannkind

19-Apr-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for MNKD by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Mannkind (MNKD) Frequently Asked Questions

What does Mannkind do?

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

What symbol and exchange does Mannkind stock trade?

Mannkind trades on the NASDAQ stock market under the symbol MNKD.

What is Mannkind stock price doing today?

As of April 19, 2024, MNKD stock price climbed to $4.18 with 1,723,890 million shares trading.

What is Mannkind's Beta?

MNKD has a beta of 0.99, meaning it tends to be less sensitive to market movements. MNKD has a correlation of 0.05 to the broad based SPY ETF.

How much is Mannkind worth?

MNKD has a market cap of $1.10 billion. This is considered a Small Cap stock.

How much money does Mannkind make?

Last quarter Mannkind reported $58 million in Revenue and $.02 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.02.

What is the highest and lowest price Mannkind traded in the last 3 year period?

In the last 3 years, MNKD stock traded as high as $5.75 and as low as $2.49.

What are the top ETFs holding Mannkind?

The top ETF exchange traded funds that MNKD belongs to (by Net Assets): VTI, IWM, XBI, VXF, IBB.

Is Mannkind (MNKD) a good investment?

MNKD stock has underperformed the market in the last year with a return of -1.9%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MNKD shares. However, MNKD has outperformed the market in the last 3 month and 2 week periods, returning +24.8% and -3.0%, while SPY returned +4.3% and -3.5%, respectively. This indicates MNKD has been having a stronger performance recently.

What is the support and resistance for Mannkind (MNKD) stock price?

MNKD support price is $3.95 and resistance is $4.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MNKD stock will trade within this expected range on the day.